Progress in the use of proteomics in the diagnosis and treatment of diabetic nephropathy

Deng Lin; Wang Shaoqing; Li Cuicui; Chen lijia

您当前的位置：

首页 >

文章列表页 >

Progress in the use of proteomics in the diagnosis and treatment of diabetic nephropathy

更新时间：2022-11-09

- Progress in the use of proteomics in the diagnosis and treatment of diabetic nephropathy
- Health Medicine Research and Practice Vol. 19, Issue 9, Pages: 171-176(2022)
- 作者机构：
  
  1. 成都医学院第一附属医院肾内科
  2. 成都医学院第二附属医院·核工业416医院肾脏内科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R587.2;R692.9
- Published：2022，
扫描看全文
Deng Lin, Wang Shaoqing, Li Cuicui, et al. Progress in the use of proteomics in the diagnosis and treatment of diabetic nephropathy. [J]. Health Medicine Research and Practice 19(9):171-176(2022)
DOI：

Deng Lin, Wang Shaoqing, Li Cuicui, et al. Progress in the use of proteomics in the diagnosis and treatment of diabetic nephropathy. [J]. Health Medicine Research and Practice 19(9):171-176(2022) DOI：

摘要

糖尿病肾病是造成糖尿病患者高死亡率的主要原因之一

也是尿毒症的首要原因(占1/3)。糖尿病肾病进展快、疗效差

因此对有糖尿病并发症发展风险的个体进行早期诊断、预防进展及治疗指导极为重要。蛋白质组学在深入探究2型糖尿病的病理生理过程和调控机制方面发挥了重要作用

可用于识别有进展性肾脏疾病风险的个体和预期治疗效果良好的患者。目前已发现许多蛋白质组学生物标志物

但这些生物标志物大多反映糖尿病肾病终末期的疾病状态

缺乏早期诊断特异性和准确性。本文主要对糖尿病肾病潜在的蛋白质组学生物标志物、有肾脏疾病风险患者早期管理等方面文献进行综述

旨在为糖尿病肾病早期诊断及判断疾病进程提供新的思路。

Abstract

Diabetic nephropathy is one of the leading causes of high mortality in diabetic patients and the leading cause of uremia

accounting for one-third of uremia. Diabetic nephropathy progresses rapidly and has poor outcomes

so early diagnosis

prevention of progression

and treatment guidance are extremely important for individuals at risk of developing diabetic complications. Proteomics plays an important role in understanding the physiological processes and regulatory mechanisms of type 2 diabetes and can be used to identify individuals at risk of progressive kidney disease and those who respond well to treatment. Plenty of proteomic markers have been identified

but most of these biomarkers reflect the disease status of endstage diabetic nephropathy and lack early diagnostic specificity and accuracy. This paper reviews the potential proteomic markers of diabetic nephropathy and the early management of patients at risk of kidney disease in order to provide new ideas for the early diagnosis of diabetic nephropathy and determine the course of the disease.

关键词

蛋白质组学糖尿病肾病生物标志物应用进展

Keywords

ProteomicsDiabetic nephropathyBiomarkersApplication progress

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Observation on the therapeutic effect of compound Ganoderma kidney invigorating method combined with Tripterygium wilfordii polyglycoside tablets in the treatment of early diabetic nephropathy

Effects of high-flux hemodialysis on metabolic waste clearance and nutritional status in patients with diabetic nephropathy

Effects of huazi dihuang decoction combined with benazepril on renal function, TCM symptoms and microcirculatory indexes in patients with diabetic nephropathy

Effects of canagliflozi n on urinary exosomal miRNA, IL-1β and E-cadherin levels in patients with type 2 diabetic nephropathy

Eff ect of transtheoretical model on glycemic control, renal function and self-care behaviors in patients with diabetic nephropathy

Related Author

Fan Jing

Yuan Fang

Li Qi

Yao Bo

Ge Lijuan

Fan Jing

Yuan Fang

Yu Long

Related Institution

The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Department of Nephropathy Dialysis, The Second Affiliated Hospital of Henan University of Science and Technology

Department of Nephrology, Affiliated Hospital of Liaoning University of Chinese Medicine

Department of Pharmacy, The First Affiliated Hospital of Nanyang Medical College

Department of Endocrinology, Fujian Provincial Hospital

⁰